Trial Profile
Withdrawing off-label antipsychotics in people with intellectual disabilities: why does it fail?
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 20 Sep 2017
Price :
$35
*
At a glance
- Drugs Pipamperone (Primary) ; Risperidone (Primary)
- Indications Behavioural disorders
- Focus Adverse reactions; Therapeutic Use
- 20 Sep 2017 New trial record